This is Where Hope Lives
Google told me I had ten years to live. Ten years. Isaiah turned 10 this year, and he’s only just begun to live a life.
The LAM Foundation Announces Interim Executive Director
On behalf of the Board of Directors of The LAM Foundation, I am thrilled to announce the arrival of Dr. Patricia A. Gentile, Ed.D, as
Statement on Pfizer’s decision on the brand drug, Rapamune, in the U.S.
The LAM Foundation was made aware just yesterday by Pfizer that they will no longer sell or have availability of their brand drug, RAPAMUNE® in
Leadership Change at The LAM Foundation
After a decade of remarkable leadership of the LAM Foundation, Sue Sherman has informed the Board of Directors of her decision to step down from
Report: Exercise with LAM is Safe and Effective
A question that comes up frequently within the LAM community is whether exercise can improve life for individuals with LAM – and if so, how
COVID-19 UPDATES
COVID-19 continues to persist in the community at a relatively low level, mainly in the form of Omicron subvariants. Omicron subvariants are highly transmissible but
The latest in LAM research
Although the FDA’s approval of sirolimus for lymphangioleiomyomatosis was a major breakthrough in treating the disease, the drug does not work for all LAM patients.
Single cell RNA sequencing provides insights into LAM and a potential link to COVID-19
Single cell RNA sequencing (scRNA-seq) is a technology that allows the analysis of transcriptome of individual cells; that is, to measure and analyze the messenger